1. Home
  2. PRSO vs RGNT Comparison

PRSO vs RGNT Comparison

Compare PRSO & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.50

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$2.08

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRSO
RGNT
Founded
2008
2004
Country
United States
Israel
Employees
N/A
8
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
14.3M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
PRSO
RGNT
Price
$0.50
$2.08
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $3.00
N/A
AVG Volume (30 Days)
★ 235.2K
37.0K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.23
N/A
EPS
N/A
★ N/A
Revenue
★ $14,573,000.00
N/A
Revenue This Year
$18.48
N/A
Revenue Next Year
$53.57
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 5.99
N/A
52 Week Low
$0.46
$1.23
52 Week High
$2.37
$15.50

Technical Indicators

Market Signals
Indicator
PRSO
RGNT
Relative Strength Index (RSI) 39.97 48.68
Support Level $0.46 $1.74
Resistance Level $0.92 $2.54
Average True Range (ATR) 0.03 0.15
MACD 0.01 0.03
Stochastic Oscillator 35.13 34.67

Price Performance

Historical Comparison
PRSO
RGNT

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: